critical care medicine limited
critical care medicine limited Company Information
Company Number
08454010
Next Accounts
Dec 2025
Industry
Hospital activities
Directors
Shareholders
celeste grace haslam
james duncan haslam & emily haslam
Group Structure
View All
Contact
Registered Address
regency house 33 wood street, barnet, EN5 4BE
Website
https://jeccm.amegroups.comcritical care medicine limited Estimated Valuation
Pomanda estimates the enterprise value of CRITICAL CARE MEDICINE LIMITED at £23.2k based on a Turnover of £42.9k and 0.54x industry multiple (adjusted for size and gross margin).
critical care medicine limited Estimated Valuation
Pomanda estimates the enterprise value of CRITICAL CARE MEDICINE LIMITED at £24.1k based on an EBITDA of £6k and a 4.02x industry multiple (adjusted for size and gross margin).
critical care medicine limited Estimated Valuation
Pomanda estimates the enterprise value of CRITICAL CARE MEDICINE LIMITED at £24k based on Net Assets of £8.9k and 2.7x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Critical Care Medicine Limited Overview
Critical Care Medicine Limited is a live company located in barnet, EN5 4BE with a Companies House number of 08454010. It operates in the hospital activities sector, SIC Code 86101. Founded in March 2013, it's largest shareholder is celeste grace haslam with a 50% stake. Critical Care Medicine Limited is a established, micro sized company, Pomanda has estimated its turnover at £42.9k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Critical Care Medicine Limited Health Check
Pomanda's financial health check has awarded Critical Care Medicine Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 6 areas for improvement. Company Health Check FAQs
2 Strong
2 Regular
6 Weak
Size
annual sales of £42.9k, make it smaller than the average company (£4.4m)
- Critical Care Medicine Limited
£4.4m - Industry AVG
Growth
3 year (CAGR) sales growth of -12%, show it is growing at a slower rate (8.1%)
- Critical Care Medicine Limited
8.1% - Industry AVG
Production
with a gross margin of 35.9%, this company has a comparable cost of product (35.9%)
- Critical Care Medicine Limited
35.9% - Industry AVG
Profitability
an operating margin of 13.2% make it more profitable than the average company (10.4%)
- Critical Care Medicine Limited
10.4% - Industry AVG
Employees
with 1 employees, this is below the industry average (48)
1 - Critical Care Medicine Limited
48 - Industry AVG
Pay Structure
on an average salary of £33.9k, the company has an equivalent pay structure (£33.9k)
- Critical Care Medicine Limited
£33.9k - Industry AVG
Efficiency
resulting in sales per employee of £42.9k, this is less efficient (£73.5k)
- Critical Care Medicine Limited
£73.5k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- Critical Care Medicine Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 0 days, this is quicker than average (31 days)
- Critical Care Medicine Limited
31 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Critical Care Medicine Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 96 weeks, this is more cash available to meet short term requirements (42 weeks)
96 weeks - Critical Care Medicine Limited
42 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 50.9%, this is a higher level of debt than the average (41.6%)
50.9% - Critical Care Medicine Limited
41.6% - Industry AVG
CRITICAL CARE MEDICINE LIMITED financials
Critical Care Medicine Limited's latest turnover from March 2024 is estimated at £42.9 thousand and the company has net assets of £8.9 thousand. According to their latest financial statements, Critical Care Medicine Limited has 1 employee and maintains cash reserves of £16.5 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||||
| Other Income Or Grants | |||||||||||
| Cost Of Sales | |||||||||||
| Gross Profit | |||||||||||
| Admin Expenses | |||||||||||
| Operating Profit | |||||||||||
| Interest Payable | |||||||||||
| Interest Receivable | |||||||||||
| Pre-Tax Profit | |||||||||||
| Tax | |||||||||||
| Profit After Tax | |||||||||||
| Dividends Paid | |||||||||||
| Retained Profit | |||||||||||
| Employee Costs | |||||||||||
| Number Of Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 1,569 | 502 | 657 | 811 | 966 | 47 | 119 | 191 | 263 | 335 | 407 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 1,569 | 502 | 657 | 811 | 966 | 47 | 119 | 191 | 263 | 335 | 407 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29,495 | 0 | 0 | 0 |
| Cash | 16,520 | 10,963 | 15,795 | 15,300 | 13,511 | 10,806 | 19,744 | 13,202 | 21,074 | 16,236 | 10,960 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 16,520 | 10,963 | 15,795 | 15,300 | 13,511 | 10,806 | 19,744 | 42,697 | 21,074 | 16,236 | 10,960 |
| total assets | 18,089 | 11,465 | 16,452 | 16,111 | 14,477 | 10,853 | 19,863 | 42,888 | 21,337 | 16,571 | 11,367 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 9,016 | 7,998 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 8,917 | 7,284 | 7,871 | 3,068 | 10,289 | 7,548 | 11,124 | 10,095 | 13,854 | 0 | 0 |
| total current liabilities | 8,918 | 7,284 | 7,871 | 3,068 | 10,290 | 7,549 | 11,125 | 10,095 | 13,854 | 9,016 | 7,998 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 298 | 95 | 125 | 154 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 298 | 95 | 125 | 154 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total liabilities | 9,216 | 7,379 | 7,996 | 3,222 | 10,290 | 7,549 | 11,125 | 10,095 | 13,854 | 9,016 | 7,998 |
| net assets | 8,873 | 4,086 | 8,456 | 12,889 | 4,187 | 3,304 | 8,738 | 32,793 | 7,483 | 7,555 | 3,369 |
| total shareholders funds | 8,873 | 4,086 | 8,456 | 12,889 | 4,187 | 3,304 | 8,738 | 32,793 | 7,483 | 7,555 | 3,369 |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||
| Operating Profit | |||||||||||
| Depreciation | 328 | 155 | 154 | 155 | 111 | 72 | 72 | 72 | 72 | 72 | 72 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | |||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 0 | 0 | 0 | 0 | 0 | 0 | -29,495 | 29,495 | 0 | 0 | 0 |
| Creditors | 1 | 0 | 0 | -1 | 0 | 0 | 1 | 0 | -9,016 | 1,018 | 7,998 |
| Accruals and Deferred Income | 1,633 | -587 | 4,803 | -7,221 | 2,741 | -3,576 | 1,029 | -3,759 | 13,854 | 0 | 0 |
| Deferred Taxes & Provisions | 203 | -30 | -29 | 154 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||||||||
| Investing Activities | |||||||||||
| capital expenditure | |||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||||||
| Financing Activities | |||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||
| interest | |||||||||||
| cash flow from financing | |||||||||||
| cash and cash equivalents | |||||||||||
| cash | 5,557 | -4,832 | 495 | 1,789 | 2,705 | -8,938 | 6,542 | -7,872 | 4,838 | 5,276 | 10,960 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 5,557 | -4,832 | 495 | 1,789 | 2,705 | -8,938 | 6,542 | -7,872 | 4,838 | 5,276 | 10,960 |
critical care medicine limited Credit Report and Business Information
Critical Care Medicine Limited Competitor Analysis
Perform a competitor analysis for critical care medicine limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other micro companies, companies in EN5 area or any other competitors across 12 key performance metrics.
critical care medicine limited Ownership
CRITICAL CARE MEDICINE LIMITED group structure
Critical Care Medicine Limited has no subsidiary companies.
Ultimate parent company
CRITICAL CARE MEDICINE LIMITED
08454010
critical care medicine limited directors
Critical Care Medicine Limited currently has 1 director, Mr James Haslam serving since Mar 2013.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr James Haslam | England | 44 years | Mar 2013 | - | Director |
P&L
March 2024turnover
42.9k
-40%
operating profit
5.7k
0%
gross margin
36%
+7.5%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
8.9k
+1.17%
total assets
18.1k
+0.58%
cash
16.5k
+0.51%
net assets
Total assets minus all liabilities
critical care medicine limited company details
company number
08454010
Type
Private limited with Share Capital
industry
86101 - Hospital activities
incorporation date
March 2013
age
12
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
March 2024
previous names
N/A
accountant
CARTWRIGHTS
auditor
-
address
regency house 33 wood street, barnet, EN5 4BE
Bank
-
Legal Advisor
-
critical care medicine limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to critical care medicine limited.
critical care medicine limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for CRITICAL CARE MEDICINE LIMITED. This can take several minutes, an email will notify you when this has completed.
critical care medicine limited Companies House Filings - See Documents
| date | description | view/download |
|---|
